• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of InsP3 receptor expression in colorectal cancer patients and its relation to metastasis and neo-adjuvant chemotherapy

Research Project

Project/Area Number 20591598
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionUniversity of Occupational and Environmental Health, Japan

Principal Investigator

HIRATA Keiji  University of Occupational and Environmental Health, Japan, 保健医療学部, 准教授 (70269059)

Co-Investigator(Kenkyū-buntansha) SHIBAO Kazunori  産業医科大学, 第1外科, 助教 (10330987)
YAMAGUCHI Koji  産業医科大学, 第1外科, 教授 (50191226)
永田 直幹  産業医科大学, 医学部, 非常勤医師 (80200377)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywordsカルシウムシグナリング / IP3レセプター / 大腸癌 / 細胞増殖 / アポトーシス / イノシトール3リン酸受容体 / 抗癌剤
Research Abstract

The inositol 1,4,5-trisphosphate receptor (InsP3R) mediates Ca2+ signaling in epithelia and regulates cel- lular functions such as secretion, apoptosis and cell proliferation. Loss of one or more InsP3R isoform has been implicated in disease processes such as cholestasis. Here we examined whether gain of expression of InsP3R isoforms also may be associated with development of disease. Expression of all three InsP3R isoforms was evaluated in tissue from colorectal carcinomas surgically resected from 116 patients. Type I and II InsP3Rs were seen in both normal colorectal mucosa and colorectal cancer, while type III InsP3R was observed only in colorectal cancer. Type III InsP3R expression in the advancing margins of tumors correlated with depth of invasion, lymph node metastasis, liver metastasis, and TNM stage. Heavier expression of type III InsP3R also was associated with decreased 5-year survival. shRNA knockdown of type III InsP3R in CACO-2 colon cancer cells enhanced apoptosis, while over-expression of the receptor decreased apoptosis. Thus, type III InsP3R becomes expressed in colon cancer, and its expression level is directly related to aggressiveness of the tumor, which may reflect inhibition of apoptosis by the receptor. These findings suggest a previously unrecognized role for Ca2+ signaling via this InsP3R isoform in colon cancer.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (4 results)

All 2010 2008 Other

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (1 results) Remarks (1 results)

  • [Journal Article] The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma2010

    • Author(s)
      Shibao K, Fiedler MJ, Nagata J, Minagawa N, Hirata K, Nakayama Y, Iwakiri Y, Nathanson MH, Yamaguchi K
    • Journal Title

      Cell Calcium 48(6)

      Pages: 315-323

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma2010

    • Author(s)
      Shibao K., Hirata K, Yamaguchi K., et al.
    • Journal Title

      Cell Calcium

      Volume: 48 Pages: 315-323

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Presentation] 大腸癌における3型イノシトール3リン酸レセプター発現は悪性度の指標となる2008

    • Author(s)
      柴尾和徳
    • Organizer
      第67回日本癌学会総会
    • Place of Presentation
      神戸市
    • Year and Date
      2008-10-28
    • Related Report
      2008 Annual Research Report
  • [Remarks] ホームページ等

    • Related Report
      2010 Final Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi